VALSCOPE
日本米国
codese.net

Bausch Health Companies Inc.

BHCUS
SEC EDGARで開く
売上高
$10.3B
百万USD
営業利益
$1.8B
百万USD
純利益
$157M
百万USD
ROE
-28.3%
最新FY
EPS
$0.42
USD / 株
配当
-
USD / 株

業績推移

収益性

キャッシュフロー

財務状況

四半期業績

年度売上高純利益EPS
FY2021Q1$2.0B$-610M$-1.71
FY2021Q2$2.1B$-595M$-1.66
FY2021Q3$2.1B$188M$0.52
FY2021FY$8.4B$-948M$-2.64
FY2022Q1$1.9B$-69M$-0.19
FY2022Q2$2.0B$-145M$-0.40
FY2022Q3$2.0B$399M$1.10
FY2022FY$8.1B$-225M$-0.62
FY2023Q1$1.9B$-201M$-0.55
FY2023Q2$2.2B$26M$0.07
FY2023Q3$2.2B$-378M$-1.03
FY2023FY$8.8B$-592M$-1.62
FY2024Q1$2.2B$-64M$-0.17
FY2024Q2$2.4B$10M$0.03
FY2024Q3$2.5B$-85M$-0.23
FY2024FY$9.6B$-46M$-0.13
FY2025Q1$2.3B$-58M$-0.16
FY2025Q2$2.5B$148M$0.40
FY2025Q3$2.7B$179M$0.48
FY2025FY$10.3B$157M$0.42
FY2026Q1$2.5B$-1.4B$-3.82

財務データ

指標FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
売上高--$8.4B$8.6B$8.0B$8.4B$8.1B$8.8B$9.6B$10.3B
営業利益$-566M$102M$-2.4B$-203M$676M$450M$454M$963M$1.5B$1.8B
純利益-----$-948M$-225M$-592M$-46M$157M
総資産$43.5B$37.5B$32.5B$33.9B$31.2B$29.2B$25.7B$27.4B$26.5B$26.4B
純資産$3.3B$5.9B$2.8B$1.1B$605M$-34M$260M$-82M$-322M$377M
自己資本$3.2B$5.8B$2.7B$1.1B$535M$-106M$-692M$-1.0B$-1.3B$-554M
営業CF$2.1B$2.3B$1.5B$1.5B$1.1B$1.4B$-728M$1.0B$1.6B$1.4B
EPS$-6.94$6.83$-11.81$-5.08-$-2.64$-0.62$-1.62$-0.13$0.42
BPS$9.06$16.77$7.79$3.01$1.50$-0.29$-1.91$-2.80$-3.48$-1.50
ROE-----894.3%32.5%57.9%3.6%-28.3%
Bausch Health Companies Inc.(BHC)の業績・財務推移 | Valscope